Key facts
- This page summarizes Jeffrey D. Alter's Form 4 filing for BIORA THERAPEUTICS, INC. (BIORQ).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Jun 2024, 16:33.
Jeffrey D. Alter - 05 Jun 2024 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)
- Reporting relationship
- Director
- Issuer ticker
- BIORQ
- Reported as of
- 05 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Jun 2024, 16:33:22 UTC
- Prior SEC filing
- 16 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Clarke Neumann, Attorney-in-Fact for Jeffrey D. Alter
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey D. Alter filed Form 4 for BIORA THERAPEUTICS, INC. (BIORQ) on 06 Jun 2024.
Change
- Previous filing in this sequence was filed on 16 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIOR
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +12,500
- Change %
- +66%
- Price
- $0.000000
- Shares after
- 31,546
- Date
- 05 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIOR
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +12,500
- Change %
- Price
- $0.000000
- Shares after
- 12,500
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,500
- Exercise price
- $0.7000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents 12,500 restricted stock units, which vest in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
Footnote F2
This option represents the right to purchase 12,500 shares of the Issuer's common stock, and vests in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.